Dirk Pamperin
Director/Board Member at SYNTHAVERSE S.A.
Dirk Pamperin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SYNTHAVERSE S.A. | Director/Board Member | 2019-12-31 | - |
APOGEPHA Arzneimittel GmbH
 APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Chief Executive Officer | 2017-12-31 | - |
| Chief Tech/Sci/R&D Officer | 2011-12-31 | 2017-12-31 |
Career history of Dirk Pamperin
Former positions of Dirk Pamperin
| Companies | Position | Start | End |
|---|---|---|---|
Synthon BV
 Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Chief Tech/Sci/R&D Officer | 2004-12-31 | 2011-12-31 |
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Corporate Officer/Principal | 1997-12-31 | 2004-12-31 |
Training of Dirk Pamperin
| Technische Universität Braunschweig | Undergraduate Degree |
| Universität Stuttgart | Doctorate Degree |
Statistics
International
| Germany | 4 |
| Poland | 2 |
| Netherlands | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SYNTHAVERSE S.A. | Health Technology |
| Private companies | 2 |
|---|---|
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Health Services |
Synthon BV
Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Dirk Pamperin
- Experience
